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Background  and  objectives:  The  emergence  of  the  recovery  movement  has  led  to  the  devel-
opment of  the  Recovering  Quality  of  Life  Questionnaire  (ReQoL)  in  the  UK.  This  study  aims  to
describe  and  evaluate  the  Dutch  translation.
Methods:  The  ReQoL  was  administered  in  two  samples:  62  students  completed  the  ReQoL-
20, MANSA,  EQ-5D-5  L,  PHQ-9  and  GAD-7  through  an  online  survey  link.  The  ReQoL  was  tested
for reliability  and  a  first  impression  was  obtained  of  convergent  and  known  group  validity.
In addition,  164  patients  with  a  psychotic  disorder  that  were  part  of  the  UP’S  cohort  study
completed  the  ReQoL-10,  PHQ9  and  GAD-7.
Results:  The  ReQoL-10  and  ReQoL-20  showed  to  be  reliable  in  the  student  sample  and  the
patient sample.  Indices  of  the  convergent  and  known-group  validity  showed  that  the  ReQoL
was predominantly  associated  with  quality  of  life  and  was  able  to  distinguish  between  scores
of patient  and  student  samples.
Conclusion:  The  Dutch  translation  of  the  ReQoL-10  and  ReQoL-20  yielded  results  in  line  with
those of  the  original  English  version.
© 2020  Asociación  Universitaria  de  Zaragoza  para  el  Progreso  de  la  Psiquiatŕıa  y  la  Salud  Mental.
Published  by  Elsevier  España,  S.L.U.  All  rights  reserved.∗ Corresponding author.
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n  mental  health  care  for  patients  with  severe  mental  dis-
rders,  there  has  been  a  shift  of  attention  from  clinical



















































































































utcomes  and  symptom  reduction  to  quality  of  life  and  func-
ional  outcomes.1,2 Many  researchers  and  clinicians  have
rgued  that  outcome  measurement  of  mental  health  care
MHC)  should  have  a  broader  focus  than  merely  assessing  the
everity  of  symptomatology  of  psychiatric  disorders.3,4 The
mergence  of  the  recovery  movement  led  to  an  increased
ttention  for  the  assessment  of  (health  related)  quality
f  life.  Quality  of  life  used  to  be  assessed  with  generic
easures,  like  the  EQ-5D-5  L4 or  with  instruments  devel-
ped  specifically  for  MHC,  such  as  the  Lancashire  Quality
f  Life  profile  (LQLP),  and  its  shorter  version,  the  Manch-
ster  Short  Assessment  of  Quality  of  Life  (MANSA).5 The
Q-5D-5  L  is  a  standardised,  non-disease-specific  short  self-
eport  questionnaire  and  has  been  used  extensively  in  both
eneral  health  care  and  mental  health  care6 in  many  coun-
ries  including  the  Netherlands.7 It  measures  health-related
uality  of  life  in  multiple  populations.4
In  recent  years,  the  recovery  movement  has  gained  trac-
ion  and  has  inspired  the  development  of  a  new  measure,
he  Recovering  Quality  of  Life  (ReQoL)  questionnaire,  under-
aken  by  the  ReQoL  Scientific  Group  at  the  University  of
heffield.  Especially  a  in  the  development  of  this  instru-
ent.  For  example,  part  of  the  ReQoL  has  been  based  on
he  CHIME  conceptual  framework  for  recovery,  which  iden-
ifies  five  parts  of  (personal)  recovery:  Connectedness,  Hope
nd  Optimism,  Identity,  Meaning  in  life  and  Empowerment.8
he  development  of  the  ReQoL  was  done  in  five  stages.
he  first  stage  consisted  of  developing  themes  for  the  ques-
ionnaire.  These  themes  were  drawn  from  reviews9,10 and
nterviews  with  service  users,11 after  which  the  item-list
as  generated  by  service-users  and  the  research  team.12
he  last  three  stages  consisted  of  testing  and  analyses  to
nvestigate  the  reliability  and  validity  of  the  ReQoL  for  ser-
ice  users  in  the  United  Kingdom.13 All  stages  were  done
y  a  core  team  of  researchers,  who  were  supported  by  a
cientific  group,  an  international  advisory  group,  a  stake-
olders’  group  and  an  expert  service  user  group.14 There
re  two  versions:  a  10-item  and  a  20-item  scale,  the  lat-
er  encompassing  more  wellbeing  items.  The  instrument  has
atisfactory  psychometric  properties:  the  reliability  (inter-
al  consistency)  for  both  the  ReQoL-10  and  ReQoL-20  in  the
K  has  been  shown  in  patient  samples  to  be  ˛  =  0.85  and
 =  0.90  respectively,  with  r  =  .98  correlation  between  the
wo  versions.  Convergent  validity  was  supported  by  a  cor-
elation  above  r  =  0.80  across  diagnostic  groups  with  other
nstruments  measuring  similar  constructs.  Furthermore,  the
eQoL  appeared  able  to  distinguish  between  clinical  and
eneral  population  samples.13
In  the  Netherlands,  there  is  an  increasing  attention  for
ecovery  beyond  mere  symptom  reduction.  Consequently,
he  assessment  of  quality  of  life  has  gained  attention  as
ell,15--17 and  the  patient  perspective  becomes  more  and
ore  important.18,19 This  is  similar  to  the  ideas  and  theoret-
cal  basis  in  the  UK.20,21 Hence,  the  ReQoL,  in  a  validated
utch  version,  could  be  a  worthwhile  alternative  to  the
Q-5D  and  the  MANSA  since  they  both  have  shown  to  be
roblematic  for  use  in  mental  health  samples.22,23 For  exam-
le,  the  EQ-5D-5L  has  an  emphasis  on  pain  and  (dis)ability3nd  the  MANSA  has  been  found  to  be  strongly  associated
ith  depressive  symptoms24--26 and  is  not  always  shown  to  be
ensitive  to  change  of  quality  of  life.27 Therefore,  we  trans-
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esearch  group  and  this  version  is  endorsed  as  the  official
utch  version.
The  aim  of  the  present  study  is  to  investigate  the  psycho-
etric  qualities  of  the  Dutch  ReQoL  version  by  comparing
cores  on  the  items  and  psychometric  properties  to  the
riginal  English  version  of  the  ReQoL.  We  administered
he  ReQoL-20  to  a  convenience  sample  (university  stu-
ents).  Convergent  validity  was  investigated  by  comparing
he  ReQoL  with  the  EQ-5D-5L  and  MANSA;  divergent  validity
ith  the  PHQ-9  and  GAD-7.  Furthermore,  we  investigated
cores  in  a  group  of  patients  with  a  diagnosis  of  psychotic
isorder  and  the  association  of  their  scores  on  the  ReQoL-10




n  order  to  investigate  the  Dutch  version,  the  ReQoL  was
dministered  to  a  Dutch  sample  of  university-level  students.
ll  students  (N  =  62)  completed  the  ReQoL-20,  the  EQ-5D-5L,
ANSA,  PHQ-9  and  GAD-7  in  a single  sitting,  and  answered
dditional  questions  about  having  any  psychological  prob-
ems  and  receiving  treatment  for  these  problems,  with  88.7
 not  receiving  any  treatment.  Age  and  gender  were  also
ssessed,  with  their  age  ranging  between  19  and  31,  with  a
ean  of  23.5  (SD  =  2.4).  Furthermore,  most  of  the  students
ere  female  (n  =  46).  Recruitment  was  done  anonymously
hrough  an  internet-link,  where  they  could  complete  the
uestionnaires  in  a  single  session.  The  link  was  brought  to
heir  attention  through  various  Social  Media  and  through
arious  University  news  channels.
atient  sample
urthermore,  in  order  to  test  divergent  validity  in  a  patient
opulation,  the  ReQoL-10  measurements  of  participants  of
he  UP’S  cohort  study  were  compared  to  PHQ-9  and  GAD-7
cores.  UP’S  is  a cohort  that  investigates  recovery  for  peo-
le  with  psychosis.  All  current  participants  of  the  cohort
tudy  that  completed  the  interview  (N  =  164)  also  completed
he  three  questionnaires,  as  part  of  that  larger  interview.
ge,  gender,  educational  level,  diagnosis  and  country  of
irth  were  also  assessed.  Participants  are  recruited  for  UP’S
t  different  Mental  Health  Care  centres  in  various  teams
pecialised  in  in-  and  outpatient  care.  All  patients  were
etween  18  and  65  years  of  age  and  were  in  care  for  having
 psychotic  disorder,  including  schizophrenia,  schizoaffec-
ive  disorder,  delusional  disorder  or  psychosis  not  otherwise
pecified.  The  interviews  were  carried  out  by  several  Flex-
ble  Assertive  Community  Treatment  (FACT)  team  members
n  the  South-Western  part  of  the  Netherlands  from  which
hey  received  treatment.  The  characteristics  of  the  cur-
ent  participants  of  the  cohort,  are  shown  in  Table  1.  The
ean  age  was  40.1  (SD  =  11.8)  at  baseline  (range  18--64)  and
6.5  %  were  male.  Furthermore,  almost  half  of  the  group
ad  a diagnosis  of  schizophrenia  (48.2  %).  For  this  group,
ymptom  scores  were  calculated  using  the  PANSS-Remission
cale.  This  scale  scores  three  positive,  three  negative  and
wo  generic  symptoms  on  a  one  to  seven  scale,  with  one  not
aving  the  symptom  and  seven  having  the  symptom  com-
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Table  1  Demographic  characteristics  of  the  student  and  patient  sample.
Student  sample  Patient  sample
N  %  N  %
Gender
Men  16  25.8  109  66.5
Women 46  74.2  55  33.5
Educational  level
Primary  school  (normal  or  vocational) --  --  32  19.5
General secondary  education  (lower,  senior,  pre-uni) -- -- 65  39.6
Higher vocational  education 5  8.1  10  6.1
University Bachelor 16  25.8  -- --
University Master  41  66.1  15  9.1
Unknown --  --  42  25.6
Receiving Care






































pletely  interfere  with  daily  life.  For  this  patient  sample,  the
mean  PANSS-R  score  was  2.0  (SD  =  0.78),  with  mean  positive
symptoms  2.1  (SD  =  1.1),  negative  2.2  (SD  =  1.0)  and  generic
1.7  (SD  =  0.9).  All  indicate  very  low  symptomatology.
Dutch  version  of  the  ReQoL
Translation
The  ReQoL  group  provided  a  license  for  translation  of  the
ReQoL  to  the  official  Dutch  version  to  CvdF-C.  To  develop
the  Dutch  version  of  the  ReQoL,  the  quality  of  the  translation
is  essential,  with  equivalence  in  both  terms  and  measured
constructs.  Therefore,  an  extensive  translation  procedure
was  followed.28,29 First,  a  translation  from  English  into  Dutch
was  made  by  a  small  workgroup  led  by  CvdF-C.  Secondly,
this  first  version  was  translated  back  to  English  by  a  native
speaker.  Any  discrepancies  between  the  original  ReQoL  and
this  translation  were  discussed  by  the  work  group  and,  when
assistance  was  needed,  discussed  with  the  original  Sheffield
workgroup.  Discrepancies  in  interpretation  or  meaning  of
items  led  to  some  revisions  of  the  Dutch  translation.  Further-
more,  the  English  version  of  the  ReQoL  contains  a  question
about  physical  symptoms,  the  scoring  of  which  is  not  consid-
ered  in  the  original  scoring  instruction.  In  the  official  Dutch
version,  a  scoring  instruction  for  that  question  was  provided
as  well.  A  technical  report  on  the  translation  process  can  be
retrieved  from  the  authors.
ReQoL  and  its  constructs
The  ReQoL  measures  Recovering  of  Quality  of  Life  for  the
last  week.  There  are  two  versions:  a  10-item  and  20-item
version.  The  items  of  the  10-item  version  are  the  first  10
items  of  the  20-item  ReQoL.  Of  the  20-items,  11  items  are
positively  worded  and  nine  are  negatively  worded.  For  the
10-item  version,  this  is  four  and  six,  respectively.  All  items
are  scored  on  a  five-level  scale,  ranging  from  ‘None  of  the
time’  to  ‘Most  of  the  time’.  For  the  positively  worded  items,
scoring  is  from  zero  to  four  whereas  the  negatively  worded
items  are  scored  from  four  to  zero.  For  both  versions,  a
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 higher  recovering  of  quality  of  life.12 For  the  purpose  of
omparing  both  versions,  a  half-score  will  be  calculated  for
he  ReQoL-20  in  this  study.
During  the  early  stages  of  the  development  of  the  ReQoL,
 themes  were  identified  as  being  important  for  recovering
uality  of  life  in  MHC:  Activity;  belonging  and  relationships;
hoice,  control  and  autonomy;  hope;  self-perception;  well-
eing;  physical  health.  These  7  themes  were  used  as  a  base
o  generate  items.12 The  ReQoL-20  version  contains  four
uestions  on  activity  (questions  1,  3,  11  and  12),  two  on
elonging  and  relationships  (questions  2  and  9),  three  on
hoice,  control  and  autonomy  (questions  4,  7  and  15),  two  on
ope  (questions  6  and  8),  2  on  self-perception  (questions  10
nd  14),  7  on  well-being  (questions  5,  13,  16,  17,  18,  19  and
0),  and  1  on  physical  health.  The  first  10  questions  of  the
eQoL-20,  make  up  the  ReQoL-10  and  therefore  all  themes
re  represented  with  two  questions,  except  self-perception,
ell-being  and  physical  health,  which  are  represented  by
 single  question.  CvdF-C  and  EdB  were  members  of  the
nternational  scientific  advisory  group.
K  version  of  the  ReQoL
o  evaluate  the  Dutch  translation  of  the  ReQoL,  comparison
ith  the  original  UK  version  of  both  the  ReQoL-10  and  ReQoL-
0  is  necessary.  Validation  and  reliability  for  the  ReQoL-10
nd  -20  have  been  established  in  the  UK  during  the  last
hree  stages  of  development  of  the  ReQoL.  For  the  reliability
ssessment,  a  sample  of  both  patients  (N  =  800)  and  gen-
ral  population  members  (N  =  2000)  were  recruited  through
 market  research  company.  The  general  population  sam-
le  was  representative  for  the  UK  general  population  in
ge,  gender,  ethnicity  and  geography.  74  %  (N  =  595)  of  the
atient  sample  reported  a  common  mental  health  disorder.
f  them,  78  %  reported  very  poor  to  fair  mental  health.  61  %
f  the  total  sample  was  female.  Half  of  the  group  completed
he  ReQoL-10,  the  other  half  completed  the  ReQoL-20.  Sub-
ets  of  the  patient  (N  =  141)  and  general  population  (N  = 350)
ompleted  a  second  measurement  two  weeks  later.  For
alidity  purposes,  4266  service  users  were  recruited  through
econdary  providers,  general  practices  and  voluntary  organ-














































































































hannel.  All  service  users  completed  a  40-item  set,  in  which
he  ReQoL-10  and  ReQoL-20  were  embedded  previous  to
etting  to  their  final  formats.  Participants  were  from  five
iagnostic  groups  and  were  well  distributed  across  groups  by
ge,  gender,  marital  status,  main  activity  and  ethnicity.  39  %
eported  good  to  excellent  mental  health  and  32  %  reported
oor  to  very  poor  general  health.  All  information  has  been
btained  from  Keetharuth  et  al.13 and  the  developmental
eport  of  the  ReQoL.12
ther  measures
Q-5D-5L  and  MANSA
he  EQ-5D-5L  measures  health-related  quality  of  life  of
oday4 with  5  items:  mobility,  self-care,  usual  activities,
ain  or  discomfort,  and  anxiety  or  depression30,31 and  can  be
sed  to  calculate  quality-adjusted  life-years  (QALYs).32 For
esponding,  all  questions  have  five  response  options,  rang-
ng  from  ‘no  problems  (1)’  to  ‘extreme  problems  (5)’.  The
Q-VAS  scale  at  the  end,  assesses  the  patients’  self-rated
ealth  on  a  vertical  0--100  scale.33
Quality  of  life  was  measured  by  MANSA,  which  is  a  short
ersion  of  the  LQLP  specifically  developed  to  counter  short-
omings  of  the  LQLP,  such  as  time  to  administer,  change
ver  time  and  comprises  items  best  suited  to  discriminate
etween  samples.34 There  is  a  12-and  a  16-item  MANSA  ver-
ion  consisting  of  only  subjective  items,  or  of  both  subjective
nd  objective  items.  Four  items  investigate  objective  qual-
ty  of  life  and  12  investigate  subjective  satisfaction  with
ife  as  a  whole,  job,  financial  situation,  friendships,  leisure
ctivities,  accommodation,  personal  safety,  people  that  the
erson  lives  with,  family  and  health.  For  this  study,  only
he  12  subjective  items  are  used.  Satisfaction  is  rated  on
 7-point  scale  ranging  from  1  =  ‘‘could  not  be  worse’’  to
 =  ‘‘could  not  be  better’’,  and  an  overall  score  of  subjective
uality  of  life  may  be  calculated.5,34,35
HQ-9  and  GAD-7
he  Patient  Health  Questionnaire’s  depression  module  (PHQ-
)  is  a  screener  for  depressive  disorder36--38 that  is  validated
nd  used  in  multiple  countries.39--41 It  is  a  9-item  self-report
uestionnaire,  with  each  item  representing  a  criterion  for
ajor  depressive  disorder  in  the  DSM-IV.  They  are  anhe-
onia,  depressed  mood,  sleep  problems,  feeling  tired,
hange  in  appetite,  negative  self-evaluation,  concentration
roblems,  psychomotor  changes  and  suicidality.  Each  item
ssesses  frequency  of  the  symptom  over  the  last  two  weeks
nd  is  scored  from  ‘Not  at  all  (0)’  to  ‘Nearly  every  day  (3)’.
 sum  score  is  then  calculated  that  can  range  from  0 to  27,
ith  scores  ranging  from  5  to  9  representing  mild  depres-
ive  symptoms,  10--14  moderate  depressive  symptoms,  and
5--27  severe  depressive  symptoms.42
The  Generalized  Anxiety  Disorder  7-item  scale  (GAD-7)  is
 brief  self-report  scale  shown  to  be  valid  and  efficient  to
creen  for  GAD.  It  consists  of  7-items  that  assesses  frequency
f  anxiety  symptoms  over  the  last  two  weeks,  with  scoring
anging  from  ‘Not  at  all  (0)’  to  ‘Nearly  every  day  (3)’.  A  total
evel  of  anxiety  severity  is  calculated  that  can  range  from
 to  21,  with  scores  ranging  from  5  to  9  representing  mild
nxiety,  10--14  moderate  anxiety,  and  15--21  severe  anxiety.
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s  asked  once  on  the  disabling  effect  of  the  symptom(s)  in
eneral.43
onvergent  validity
he  ReQoL  is  based  on  7-themes,  which  are  activity,  auton-
my,  belonging  and  friendships,  hope,  self-perception  and
ell-being.  The  MANSA  is  based  on  life  as  a  whole,  a
ob,  financial  situation,  number  and  quality  of  friendships,
eisure  activities,  accommodation,  personal  safety,  people
hat  the  individual  lives  with,  sex  life,  relationship  with
amily,  physical  health  and  mental  health.  Each  question  of
he  EQ-5D  represents  mobility,  self-care,  usual  activities,
ain  or  discomfort,  and  anxiety  or  depression.  Comparison
etween  the  measurements  results  in  the  hypothesis  that
orrelations  between  some  subscales  might  be  higher  than
etween  others.  An  overview  of  the  comparison  is  given  in
able  2.  For  example,  it  is  expected  higher  correlations  will
e  found  between  the  ReQoL  subscale  ‘activity’  and  the
ANSA’s  ‘Leisure  activities’.  Likewise,  high  correlations  are
xpected  to  be  found  between  the  ReQoL  ‘Hope’  subscale
nd  the  MANSA’s  ‘Life  as  a  whole’.  A  high  negative  corre-
ation  is  expected  to  be  found  between  the  same  ReQoL
ubscale  and  the  EQ-5D  anxiety  item.
nalysis
kewness  and  kurtosis  of  the  ReQoL  items  were  considered
nd  compared  to  the  English  original.  Three  scores  were  cal-
ulated:  the  ReQoL-20  total  score,  the  ReQoL-10  total  score,
nd  a  ReQoL-20  half  score;  this  last  score  allows  for  direct
omparison  with  the  ReQoL-10  scores,  as  was  also  done
n  analyses  of  the  ReQoL  UK  version.  Furthermore,  scores
or  the  physical  question  of  the  ReQoL  were  calculated  for
oth  the  student  and  patient  sample.  Cronbach’s  alpha  was
etermined  and  inter-item  correlations  calculated.  Pear-
on’s  product  moment  correlation  coefficients  were  used  to
et  an  impression  of  the  convergent  validity  between  the
eQoL-20,  EQ-5D-5L  and  MANSA  in  a  student  population.  Fur-
hermore,  the  ReQoL-10  and  ReQoL-20  scores,  as  well  as  the
HQ-9  and  GAD-7  for  both  samples  were  assessed.  For  the
HQ-9  and  GAD-7,  clinical  cut-off  scores  (≥  10)  were  used
s  described  by  Kroenke  et  al.42 to  get  an  impression  of  the
nown  group  validity.  Analyses  will  be  done  using  SPSS  24.0.
esults
asic  psychometrics
ithin  the  student  sample,  inspection  of  the  distributions  of
he  individual  items  revealed  a  substantial  deviation  from
he  normal  curve  for  item  16  with  75.8  %  of  the  respondents
hoosing  the  most  extreme  response  category.  The  distribu-
ion  of  the  items  two  and  six  was  skewed  as  well,  although
ess  substantial.  Means,  standard  deviations,  skewness  and
urtosis  and  range  of  summed  scale  scores  are  presented  in
able  3  The  mean  and  standard  deviation  for  the  ReQoL-
0  and  -20  (half  score)  in  the  student  sample  was  27.9
SD  =  6.9)  and  27.9  (SD  =  7.3)  respectively.  For  the  patient
ample,  inspection  of  the  individual  items  on  the  ReQoL-10
howed  no  substantial  deviations,  although  most  items  were
omewhat  skewed.  Item  6  showed  to  be  most  skewed.  For
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Table  2  Impression  of  the  themes  of  the  ReQoL  with  subscales  of  other  measures.
ReQoL  MANSA  EQ-5D
Activity  Leisure  activities Daily  activities
Autonomy Job,  Finances
Belonging  and  friends  Friendships  and  relationships  with  family
Hope Life  as  a  whole  Anxiety/depression
Self-perception  Self-care
Well-being Safety,  Mental  health  and  accommodation  Mobility
Physical health  Physical  health  Pain  and  discomfort
Table  3  Distribution  of  scores  on  the  ReQoL.
N  Mean  SD  Range  Skewness  Kurtosis
ReQoL-20  (Scale  0--80) 62  55.6  13.7  22-77  −.48  −.69
ReQoL-20 (Scale  0--40) 62  27.8  6.9  11-38.5  −.48  −.69
ReQoL-10 (Scale  0--40) 62  27.9  7.3  11-39  −.48  −.69
ReQoL-10 (Scale  0--40)a 164  25.5  7.7  0-40  −.67  .35
ReQoL Physical  (scale  0--4) 62  3.0  1.0  0-4  −.85  .18




























this  patients’  sample,  only  the  ReQoL-10  total  score  could
be  calculated,  showing  a  mean  of  25.5  (SD  =  7.7).  Means  are
higher  compared  to  the  original  version,  were  the  ReQoL-
10  was  shown  to  have  a  mean  of  21.99  (SD  =  10.3)  and  the
ReQoL-20  of  21.63  (SD  =  9.97).
Reliability
Cronbach’s’  alpha  for  the  ReQoL-20  in  the  student  sample
was  ˛  =  0.94  (  =  0.93  UK  version12).  Furthermore,  the  inter-
item  correlation  was  r  =  0.44  (range  =  0.15  to  0.83)  indicating
sufficient  association  among  the  items.  Cronbach’s  alpha  for
the  extracted  ReQoL-10  was  ˛  =  0.90  (˛  =  0.87  UK  version12),
with  an  inter-item  correlation  of  r  =  0.47  (range  =  0.17  to
0.83).  For  the  patient  sample,  the  Cronbach’s  alpha  for  the
ReQoL-10  items  was    =  0.87  (˛  =  0.92  UK  version15).  Here,
the  inter  item  correlations  was  r  =  0.40  (range  =  −0.03  to
.67).
Convergent  validity
In  this  study,  only  student  data  is  available  for  the  ReQoL-
20,  MANSA,  and  EQ-5D-5  L.  However,  a  first  impression  of  the
convergent  validity  can  be  obtained  with  this  group.  The
short  and  long  version  of  the  ReQoL  show  similar  correla-
tions,  both  were  significant  (p  <  0.001)  and  all  correlations
were  in  the  correct  direction.  Correlation  between  the
ReQoL-10  and  ReQoL-20  was  r =  0.97.  Furthermore,  psycho-
metric  properties  are  similar  between  both  versions.  The
ReQoL-10  correlated  r  =  0.74  (0.76  after  deleting  the  phys-
ical  health  subscale)  with  the  MANSA  and  the  ReQoL-20
showed  a  correlation  of  r =  0.72  (0.75  after  deleting  the
physical  health  subscale)  with  the  MANSA.  Correlations  with
the  EQ-5D-5  L  were  r  =  −0.58  for  both  and  thus  overall  lower





Subscales  for  all  measures  have  been  calculated.  Corre-
ations  between  the  themes  of  the  ReQoL  and  the  themes  of
he  MANSA  and  items  of  the  EQ-5D  are  shown  in  Table  4.
Although  correlations  are  overall  low,  there  does  seem
o  be  a  pattern  of  correlations  as  is  expected:  high  between
imilar  constructs  and  generally  lower  between  dissimilar
onstructs.  For  instance,  the  correlation  between  the  ReQoL
heme  autonomy  and  the  MANSA  life  as  a  whole  was  high
r  =  .78),  as  is  the  correlation  between  the  same  MANSA
heme  and  the  ReQoL  total  score  (r  =  .79).  For  the  EQ-5D,
epression-anxiety  correlated  highly  negatively  with  the
eQoL  themes  autonomy  (r  =  −.71),  hope  (r  =  −.74),  self-
erception  (r  =  −.71)  and  well-being  (r  =  −.81),  and  with  the
otal  score  of  the  ReQoL  (r  =  −.81).  Overall,  the  correlations
f  the  MANSA  theme  ‘Life  as  a  whole’  were  high  with  all
hemes  of  the  ReQoL,  as  were  the  correlations  between  the
ANSA’s  ‘Leisure  activities’  and  Total  score,  and  all  ReQoL
hemes.
The  physical  impairment  on  the  ReQoL  showed  low  cor-
elations  with  the  MANSA  physical  subscale  and  somewhat
igher  correlations  with  the  EQ-5D  VAS  scale  and  the  EQ-5D
ain  and  discomfort  question  (r  =  .41,  r  =  .59  and  r  =  −0.65
espectively).  Furthermore,  correlations  between  this  ques-
ion  and  all  other  subscales  of  both  the  MANSA  and  EQ-5D
ere  low.
irst  impression  of  known-group  validity
he  ReQoL-10  and  ReQoL-20  scores  were  higher  for  the  stu-
ent  sample  than  for  the  patient  sample,  although  not  much.
he  range  of  scores  for  the  students  was  smaller,  indicating
hat  there  were  no  student  respondents  with  a  very  low  QoL.
 small  to  medium  Cohen’s  d (0.32)  between  the  samples
as  found.  The  ReQoL-20  total  half  score  for  the  students
as  calculated  for  comparison  and  showed  almost  no  men-
104  B.C.  van  Aken  et  al.
Table  4  Correlations  between  the  themes  of  the  ReQoL  and  corresponding  themes  on  other  measures.
ReQoL  themes  MANSA  EQ-5D
N  =  62  LA  JF  FR  Li  SMA  PH  Total  score  DA  SC  MOB  ANX  PD  Total  score
Activity  .59  .39  .42  .68  .44  .26  .56  −.40  −.04a −.07a −.60  −.37  −.47
Autonomy .69  .50  .52  .78  .50  .44  .69  −.36  −.13a −.15a −.71  −.37  −.55
Belonging and  friendships  .57  .24a .50  .64  .67  .37  .67  −.39  −.18a −.23a −.63  −.20a −.48
Hope .63  .30  .36  .67  .42  .24a .53  −.16a −.20a −.16a −.74  −.09a −.38
Self-perception  .61  .32  .44  .64  .51  .23a .57  −.25a −.11a −.02a −.71  −.21a −.40
Well-being .64  .32  .46  .68  .62  .35  .66  −.34  −.25  −.24a −.81  −.25  −.59
Physical health .44  .29  .43  .53  .27  .41  .48  −.40  −.13a −.21a −.21a −.65  −.46
Total score .73  .40  .53  .79  .68  .38  .72  −.39  −.19a −.18a −.81  −.31  −.58
a Non-significant correlations/LA = Leisure activities, JF = Job and Finances, FR = Friendships and Relationships with family, Li = Life
as a whole, SMA = Safety, Mental Health and accommodation, PH = Physical Health, DA = Daily Activities, SC = Self-care, MOB = Mobility,
ANX = Anxiety/Depression, PD = Pain and discomfort/correlations in bold are the correlations for similar constructs as mentioned in
Table 2/correlations in italics are high (>.70) correlations between different constructs.
Table  5  Known  --  group  validity  for  the  ReQoL.
ReQoL-10  ReQoL-20
n  Mean  SD  Range  T  p  n  Mean  SD  Range  T  p
Student  sample  vs  patient  sample
Student  sample  62  27.91  7.3  11--39  62  27.77  6.9  11--38.5
Patient sample  163  25.48  7.8  0--40  −2.14  .034  --  --
Comparing clinical  cut-offs  used  in  clinical  practice
PHQ-9  clinical  versus  non-clinical  score  complete  samplea
Clinical  (score  ≥  10)  68  18.75  7.1  0--34  14  18.64  4.3  11--27
Non-clinical 154  29.40  5.4  12--40  11.04  <0.001  48  30.44  4.9  20--38.5  8.15  <0.001
GAD-7 clinical  versus  non-clinical  score  complete  samplea
Clinical  (score  ≥  10) 50  18.76  7.6  0--34  5  17.70  4.0  11--24.5











































a Participants did not fill in the ReQoL-20. Therefore, scores for
ionable  difference  in  mean  and  range  with  the  ReQoL-10
cores  of  the  same  sample.  Only  SD  differed  a  bit.  For  the
ntire  sample  (both  students  and  participants),  ReQoL-10
cores  for  the  PHQ-9  clinically  scoring  sample  was  lower  than
or  those  non-clinical,  as  shown  in  Table  5.  Cohen’s  d  was
.69  for  the  PHQ-9  groups  on  the  ReQoL-10,  and  d  =  2.6  for
he  ReQoL-20.  For  the  GAD-7  groups,  Cohen’s  d  was  1.42  for
he  ReQoL-10  and  2.5  for  the  ReQoL-20.  The  means  were
hown  to  a  bit  higher  again  compared  to  the  original  UK
tudy.  For  example,  the  PHQ-9  clinical  sample  mean  on  the
eQoL-10  was  15.73  (SD  =  7.53)  and  for  the  ReQoL-20  15.23
SD  =  7.08)  in  the  UK.  For  the  non-clinical  sample,  these  were
7.37  (SD  =  6.83)  and  27.38  (SD  =  6.57),  respectively,  which
re  lower  than  shown  in  Table  5.
iscussion
his  study  reported  on  the  development  and  evaluation  of
he  translation  of  the  official  Dutch  version  of  the  Recov-
ring  Quality  of  Life  questionnaire  to  Dutch.  Translation
f  the  ReQoL  has  been  done  according  to  international
ranslation  standards,  with  a  translation  and  back  trans-
ation,  involvement  of  a  native  speaker  and  a  discussion





e in the complete sample consists of the students only.
nd  back  translations,  leading  to  adjustments  in  the  first
utch  translation.28,29 Some  skewness  on  the  items  shows
o  be  similar  to  the  original  ReQoL-20  measure,  where
he  presence  of  some  items  showed  to  be  redundant  but
ere  left  in  to  assess  concepts  more  extensively.16 How-
ver,  skewed  distribution  of  responses  on  item  16  showed
o  be  extreme  during  analyses.  This  item  represents  anxi-
ty  and  showed  skewness  as  could  be  expected  in  a  sample
f  healthy  respondents.  However,  a  similar  pattern  on  this
tem  has  not  been  seen  for  the  general  population  in  the  orig-
nal  ReQoL  validation13 and  current  wording  does  instigate
xtreme  answers.  The  item  therefore  lacks  informational
alue  and  will  be  rephrased.  Although  other  items  showed
o  be  skewed  as  well,  skewness  and  kurtosis  for  these  items
id  not  suggest  they  should  be  rephrased.
Evaluation  of  the  Dutch  version  of  the  ReQoL  showed
romising  results.  To  start,  reliability  is  shown  to  be  good
or  the  ReQoL-20  and  the  ReQoL-10  in  a  student  sample
nd  for  the  ReQoL  10  in  a  patient  sample.  Cronbach’s  alpha
as  similar  to  the  original  version  on  all  occasions.  Cor-elation  between  the  two  measures  in  a  student  sample
as  high,  which  is  also  in  line  with  the  original  validation
tudy  by  Keetharuth  et  al.13 Furthermore,  a  first  impres-


















































The  Dutch  Recovering  Quality  of  Life  questionnaire  
the  MANSA,  but  lower  correlations  with  the  EQ-5D.  Although
the  original  version  showed  higher  correlations  with  the
SWEMWBS  and  CORE-10,  the  correlation  between  the  MANSA
and  ReQoL  were  satisfactory  for  a  small  sample.  Further-
more,  the  discrepancy  in  time  period  per  questionnaire
(day,  week,  two  weeks)  may  have  suppressed  the  inter-
correlations,  which  could  also  explain  the  lower  correlations
between  the  MANSA  and  the  ReQoL  compared  to  the  origi-
nal.  High  correlations  were  found  between  the  ReQoL  and
the  EQ-5D  anxiety  scale,  which  is  in  line  with  the  main  cri-
tique  on  the  EQ-5D  that  it  emphasizes  too  much  on  pain  and
disability.3 Validity  of  the  ReQoL  is  further  supported  by  the
high  correlation  between  the  MANSA  ‘life  as  a  whole’  item
and  the  ReQoL  total  score.  The  substantial  negative  correla-
tion  between  the  mood/anxiety  item  of  the  EQ-5D  and  the
themes  of  hope,  self-perception  and  well-being,  shows  that
the  ReQoL  measures  these  ‘opposites  of  anxiety’  well.
Convergent  validity  was  first  supported  by  increasing  cor-
relations  between  the  ReQoL  measure  and  the  MANSA  when
physical  items  of  the  MANSA  were  deleted.  The  increas-
ing  correlations  are  in  line  with  the  notion  that  the  ReQoL
measures  non-physical  domains  of  health-related  quality  of
life,  with  less  emphasis  on  pain  and  disability.  Secondly,  the
ReQoL  Physical  health  question  correlated  high  with  the  Pain
and  Disability  scale,  the  EQ-5D  VAS  scale  and  the  total  score
of  the  EQ-5D.  All  underline  that  the  ReQoL  is  indeed  more
focused  on  the  non-physical  domains  of  QoL  and  less  on
pain  and  disability.  At  the  same  time,  it  shows  the  need
for  a  separate  physical  question  with  separate  scoring.  The
non-physical  domains  of  quality  of  life  are  most  relevant  for
patients  in  MHC  and  therefore  should  be  the  main  core.
Surprisingly,  the  convenience  sample  in  this  study  showed
lower  quality  of  life  compared  to  the  general  population
in  the  original  English  study.  This  could  be  explained  by
the  nature  of  the  convenience  sample,  namely  the  sample
consisting  of  students.  Recent  research  showed  that  quality
of  life  is  low  compared  to  non-studying  peers,44 making  it
harder  to  distinguish  between  them  and  the  patient  group.
However,  an  impression  of  the  known-group  validity  showed
that  the  ReQoL  is  able  to  distinguish  between  clinical  pop-
ulations.  Again,  these  measures  show  similar  results  to  the
original  study.
Overall,  the  findings  show  that  this  official  Dutch  version
of  the  ReQoL  is  valid.  Furthermore,  the  correlations  between
the  physical  health  question  and  the  EQ-5D  shows  the  valid-
ity  and  applicability  of  this  question  and  supports  the  use
of  norm  scores  for  this  question.  Overall,  these  advantages
over  existing  measures,  along  with  the  fact  that  the  ReQoL
was  developed  from  a  service  users’  perspective15 make  the
official  Dutch  ReQoL  a  valuable  instrument  for  the  Nether-
lands.
Limitations
There  are  several  limitations  to  this  study.  A  convenience
sample  was  used  to  test  the  ReQoL  and  they  were  not
be  representative  for  the  population  given  for  example
their  dispersion  of  gender.  Complete  data  for  the  patient
population  was  not  yet  available,  making  it  impossible  to
calculate  reliability  of  the  ReQoL-20  and  test-retest  validity




on  between  groups  on  the  ReQoL  measures,  as  well  as  the
se  of  clinical  cut  off  in  this  group  might  have  been  compro-
ised  by  limitations  in  both  the  convenience  sample  and
he  patient  sample.  The  convenience  sample  of  students
howed  low  ReQoL  scores  in  general,  which  might  be  a  result
f  current  pressure  on  students.  The  patient  population,  on
he  other  hand,  did  show  similar  results  on  the  ReQoL  as
ompared  to  the  original  version,  but  also  showed  to  be  a
linically  stable  group  with  almost  no  symptomatology.  One
ight  argue  that  this  does  influence  their  quality  of  life
core.  Like  the  English  original,  the  validation  results  were
alculated  on  the  embedded  ReQoL-10.  In  an  ideal  situa-
ion,  participants  would  be  randomly  assigned  to  either  the
eQoL-10  or  the  ReQoL-20.  This  can  be  done  when  data  col-
ection  on  the  ReQoL-20  is  completed.  Their  measures  can
hen  be  compared  to  that  of  the  current  patient  population.
ow,  convergent  validity  could  not  be  fully  calculated  since
here  was  no  patient  data  available  for  the  ReQoL-20,  the
ANSA  and  the  EQ-5D.  Furthermore,  the  student  population
as  expected  to  score  higher  than  the  patientsśample  on
uality  of  life  measures  and  with  a  smaller  range  of  scores
hich  limits  the  association  with  other  QoL  measures.  How-
ver,  the  large  patient  population  recruited  across  multiple
HC  organizations,  does  make  this  sample  ideal  for  use  of
he  ReQoL.
urther research
lthough  evaluation  of  the  measure  in  a  student  sample,
s  well  as  evaluation  of  the  short  version  of  the  measure
n  a  patient  population  has  shown  some  promising  results,
urther  research  is  needed.  First,  it  is  advised  to  study  the
utch  version  of  the  ReQoL-20  in  a  patient  population,  as
ell  as  a  general  population  sample.  Although  the  latter  has
een  done,  gender  diversity  in  the  sample  was  low,  with
ost  of  the  student  sample  being  female.  Furthermore,  due
o  ongoing  research,  no  data  was  available  to  evaluate  test-
etest  reliability  in  a  patient  sample,  nor  was  it  possible  to
t  a  bifactor  CFA  model  in  a  patient  sample,  as  is  standard  in
alidation  studies.  Comparison  with  studies  on  the  original
K  version  of  the  ReQoL  is  advised.
thical considerations
his  study  has  been  evaluated  and  approved  by  the  accred-
ted  Dutch  Medical  Ethical  Trial  Committee  (METC)  of  the
rasmus  Medical  Centre,  as  part  of  the  UP’S  cohort  study.
tudents  provided  digital  consent  as  part  of  the  online  ques-
ionnaire.  All  patients  provided  written  informed  consent.
unding
he  UP’S  cohort  study  is  funded  by  all  participating  Mental
ealth  institutions  and  the  governing  body  of  the  City  of
otterdam.onflict of interest
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